Overview
Validation of pharmaceutical manufacturing processes is a very important element of GMP in order to provide high level of confidence on the quality of finished product and is a mandatory compliance requirement of FDA. Risk based approach for process validation allows the management to focus on critical aspects of the manufacturing process and build adequate controls to ensure quality of the finished product. The webinar not only provides an overview of the regulatory expectations in this aspect, but also provides an insight into how to execute the validation using risk approach to ensure a robust manufacturing process throughout the life cycle of the product.
Why you should Attend
To understand and interpret regulatory expectations and develop a scientific approach to execute validation of the manufacturing process based on risk.
Areas Covered in the Session
Who Will Benefit
Dr. Ganesh Prasad is a freelance Pharma consultant in India under the banner ‘Q_Pharma consulting India & holds a doctorate degree in Organic Chemistry from Indian Institute of Science, Bengaluru. Previously, he worked at senior levels in pharmaceutical companies like Apotex Pharmachem India Pvt Ltd, ICI Pharmaceuticals, India and other organisations heading QA/QC/Process functions. He has also worked as scientist in the US FDA laboratory in Washington and other reputed institutions in USA/ Canada/India. He has together more than 30 years of experience together in quality assurance function, research in academia and industry. As a consultant he has assisted many pharmaceutical companies towards establishing cGMP standards of US FDA, European and Indian regulatory agencies. He also conducts third party quality audits of pharmaceutical manufacturers. He has conducted many public and in-house workshops and delivered invited lectures in forums like UBM, ISPE, DIA and so on.